| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 10/22/2008 | CN100427498C A-type crystal of Clarithromycin |
| 10/22/2008 | CN100427489C Process for preparing azlocillin sodium |
| 10/22/2008 | CN100427479C Photochromic perfluoro cyclopentene diaryl ethylene schiff base compound, and its preparing method and use |
| 10/22/2008 | CN100427119C Preparation for fish gold and its preparing method |
| 10/22/2008 | CN100427117C Chinese proprietary medicine |
| 10/22/2008 | CN100427093C 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor |
| 10/22/2008 | CN100427088C Paracetamol pseudoephedrine hydrochloride and cholrphenamine maleate oral cavity disintegration tablet for treating cold and preparation method thereof |
| 10/22/2008 | CN100427084C Oral silybin sustained release agent and preparation thereof |
| 10/22/2008 | CN100427082C Application of hydroxybenzoate acid and its analogue in the preparing process of medicine for preventing and treating virus infection |
| 10/22/2008 | CN100427078C Decanoyl acetaldehyde compound and its medicinal composition |
| 10/22/2008 | CN100427075C Isatidis soft capsule and preparing method thereof |
| 10/22/2008 | CN100427071C Cold treating dripping pills and its preparation method |
| 10/22/2008 | CN100427068C Kangai drip pill for treating tumour, hepatitis B and its preparation method |
| 10/22/2008 | CN100427067C liver protection drip pill and its preparation method |
| 10/21/2008 | US7439418 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide |
| 10/21/2008 | US7439258 Viral polymerase inhibitors |
| 10/21/2008 | US7439253 for example: the triethylammonium salt of 5,6-dihydro-6-oxo-N2-phenyl-5(sulfoxy)-4H-4,7-methanopyrazolo[3,4-e][1,3]diazepine-2,8(8H)-dicarboxamide |
| 10/21/2008 | US7439252 Ascomycin crystalline forms and preparation thereof |
| 10/21/2008 | US7439228 Bioactive peptides |
| 10/21/2008 | US7439225 Culturing Rhodococcus; antitubercular agents; side effect reduction |
| 10/21/2008 | US7439224 Indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals |
| 10/21/2008 | US7439063 Providing acute neuroprotection by contacting neuronal cells with erythropoietin or active fragment or analog thereof close to or subsequent to time of excitatory insult and contacting cells with insulin-like growth factor, thereby producing synergistic acute neuroprotective effect; Alzheimer's disease |
| 10/21/2008 | US7439053 Modified wild strain of enteroinvasive Shigella; cannot spread within and from infected cells to uninfected cells; vaccines; deactivation by inserting transposon into gene; does not disrupt capillaries in intestinal mucosa or release erythrocytes; mutagenizing; genetically engineered by allelic exchange |
| 10/21/2008 | US7438924 Dry granulated formulations of azithromycin |
| 10/21/2008 | US7438919 An isolated protein; vaccines |
| 10/21/2008 | CA2333648C Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 10/21/2008 | CA2270893C N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity |
| 10/21/2008 | CA2232294C Bioactive factors of aloe vera plants |
| 10/21/2008 | CA2230452C Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
| 10/21/2008 | CA2220226C Improved methods for transfecting t cells |
| 10/16/2008 | WO2008124821A1 Antibacterial 1,4,5-substituted aminoglycoside analogs |
| 10/16/2008 | WO2008124681A2 Methods and systems for treating cell proliferation disorders |
| 10/16/2008 | WO2008124647A2 Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof |
| 10/16/2008 | WO2008124550A1 Phenothiazin derivatives for antiviral treatments |
| 10/16/2008 | WO2008124210A1 Methods and compositions for treating or preventing infection using leukocyte sequestration agents |
| 10/16/2008 | WO2008123582A1 Tetrahydroisoquinoline compound |
| 10/16/2008 | WO2008123102A1 Anti-viral agent |
| 10/16/2008 | WO2008122741A1 Conjugated fatty acids and poly-l-lysine for combating pathogenic micro-organisms |
| 10/16/2008 | WO2008122687A1 Protein gp120 polypeptide capable of inhibiting the life cycle of the aids virus |
| 10/16/2008 | WO2008091752A3 Quinolone carboxylic acids, derivatives thereof, processes for their preparation and their use as antibacterial agents |
| 10/16/2008 | WO2008073863A3 Preparation and utility of substituted allylamines |
| 10/16/2008 | WO2008058547A3 Alpha-lactalbumin composition |
| 10/16/2008 | US20080255252 Infectious Aetiology of Prostatic Disease and Methods to Identify Causative Agents |
| 10/16/2008 | US20080255225 Botanical Extract Composition |
| 10/16/2008 | US20080255203 substituted oxadiazole and derivatives; novel allosteric modulators; nicotinic acetylcholine receptors modulators; central nervous system disorders; analgesics; 2,5-di(pyridin-3-yl)-1,3,4-oxadiazole |
| 10/16/2008 | US20080255191 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 10/16/2008 | US20080255190 Bactericides for grampositive and gramnegative infections |
| 10/16/2008 | US20080255189 using an thiourea compound or carbonyl thiourea compound; therapy for drug resistant infections |
| 10/16/2008 | US20080255166 E.g., 5-dinitro-2-dimethyldithio-carbamoyl-pyridine; strong bacteriacidal activity, especially against mycobacteria; tuberculosis and leprosy caused by mycobacteria and infectious diseases caused by staphylococci; side effect reductions; effective against drug, multidrug-resistant infections |
| 10/16/2008 | US20080255163 Compounds such as 2-piperidino-6-methyl-5-oxo-5,6-dihydro-(7H) pyrrole-[3,4-d]pyrimidine maleate (MS-818); nervous system, brain, and neurodegenerative disorders; Parkinson's, Alzheimer's, and Huntington's disease |
| 10/16/2008 | US20080255126 Inhibitors of post-proline cleaving proteases |
| 10/16/2008 | US20080255116 Therapy for bacteria infections other than Mycibacterium infections; antibiotic resistance |
| 10/16/2008 | US20080255108 Novel thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 10/16/2008 | US20080255105 Biphenyl Derivatives and Their Use in Treating Hepatitis C |
| 10/16/2008 | US20080255076 Steroid-Derived Pharmaceutical Compositions |
| 10/16/2008 | US20080255063 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF |
| 10/16/2008 | US20080255060 Semi-synthetic antimicrobial;therapy or prophylaxis of systemic or topical infections; 4''-O-(3-{4-[3-(3-Ethoxycarbonyl-1-ethyl-4-oxo-1,4-dihydro-quinolin-6-yl)-prop-2-ynyl]-piperazin-1-yl}-propionyl)-azithromycin; excipient, diluent, carrier |
| 10/16/2008 | US20080255055 Use of Derivatives of Dipeptides for the Manufacture of of a Medicament for the Treamtent of Microbial Infections |
| 10/16/2008 | US20080254148 Herbal compositions for the inhibition of human immunodeficiency virus |
| 10/16/2008 | US20080254127 Inhalation particles incorporating a combination of two or more active ingredients |
| 10/16/2008 | US20080254105 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 10/16/2008 | US20080254079 Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology |
| 10/16/2008 | US20080254063 Vaccines and Methods to Treat Canine influenza |
| 10/16/2008 | US20080254058 Or surface-coupled proteins; a multivalent heterologous protein display vehicle; vaccines for infectious diseases, cancer, allergies, and autoimmune diseases |
| 10/16/2008 | US20080254057 Minimizing carrier-induced epitopic suppression in combination vaccines by minimizing the amount of unconjugated carrier protein; vaccines based on conjugated capsular saccharides from multiple serogroups |
| 10/16/2008 | US20080254052 Molecular differences between species of the m. tuberculosis complex |
| 10/16/2008 | US20080254049 Composition for Treatment of Colds and Associated Symptoms |
| 10/16/2008 | US20080254039 Prevention of Thrombus Formation and/or Stabilization |
| 10/16/2008 | US20080254034 Microbial membrane protein for use in diagnosis, prevention and treatment of gramnegative bacterial infection |
| 10/16/2008 | US20080254015 For application to wounds; bacteriostats |
| 10/16/2008 | US20080254014 Use of Recombinant Yeast Strain Producing an Anti-Inflammatory Compound to Treat Colitis |
| 10/16/2008 | US20080254010 Controlling Clostridium difficile-Associated Disease in the Gastrointestinal Tract |
| 10/16/2008 | US20080253995 For treatment of Flaviviridae infection, including hepatitis C virus, West Nile Virus, yellow fever virus, and rhinovirus infection |
| 10/16/2008 | US20080253976 Personal Care Compositions Comprising An Antimicrobial Blend of Essential Oils or Constituents Thereof |
| 10/16/2008 | CA2688736A1 Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology |
| 10/16/2008 | CA2686513A1 Antiviral treatments |
| 10/16/2008 | CA2684957A1 Antibacterial 1,4,5-substituted aminoglycoside analogs |
| 10/16/2008 | CA2683046A1 Non-nucleoside reverse transcriptase inhibitors |
| 10/15/2008 | EP1980617A1 Improved expression of HIV polypeptides and production of virus-like particles |
| 10/15/2008 | EP1980564A1 Antibiotics containing borinic acid complexes and methods of use |
| 10/15/2008 | EP1980269A1 Prevention of staphylococcus biofilm formation |
| 10/15/2008 | EP1980268A2 Vaccination methods against avian influenza virus |
| 10/15/2008 | EP1980253A1 Use of meloxicam formulations in veterinary medicine |
| 10/15/2008 | EP1980251A1 Pyrrolo[3,2,1-ij]quinoline-4-one derivatives for treating tuberculosis |
| 10/15/2008 | EP1979480A2 Inhibition of viral gene expression using small interfering rna |
| 10/15/2008 | EP1979367A2 Quinolin-4-one derivatives as modulators of abc transporters |
| 10/15/2008 | EP1979315A2 Methods for treating hepatitis c |
| 10/15/2008 | EP1978980A1 Use of a combination of ethanolic rosa sp . , urtica dioica and tanacetum vulgare extracts, further comprising selenium and urea and having been exposed to a pulsed electromagnetic field, for the preparation of a medicament for immunostimulation and/or treatment of hiv infections |
| 10/15/2008 | EP1978976A2 Use of gallium to treat biofilm-associated infectons |
| 10/15/2008 | EP1978972A1 Use of alkylglucoside esters as beta-defensin inducers |
| 10/15/2008 | EP1978968A2 Cationic steroid antimicrobial compositions for treating or preventing hiv infections |
| 10/15/2008 | EP1978960A1 Use of 6-(3-chloro-2-fluorobenzyl)-1-ý(2s)-1-hydroxy-3-methylbutan-2-yl¨-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection |
| 10/15/2008 | EP1742642B1 Phosphonate analogs of hiv integrase inhibitor compounds |
| 10/15/2008 | EP1660085B1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 10/15/2008 | EP1628655A4 Antiseptic compositions, methods and systems |
| 10/15/2008 | EP1587585B1 Acylsulfonamide compounds as inhibitors of rna-dependent rna (viral) polymerases |
| 10/15/2008 | EP1567520B1 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
| 10/15/2008 | EP1544199B1 Nitrogenous condensed-ring compound and use thereof as hiv integrase inhibitor |
| 10/15/2008 | EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 10/15/2008 | EP1446162B1 Combination motif immune stimulatory oligonucleotides with improved activity |